S6927358
Vilanteroltrifenatate , ≥95%(HPLC) , 503070-58-4
Synonym(s):
4-[(1R)-2-({6-[(2-{[(2,6-Dichlorophenyl)methyl]oxy}ethyl)oxy]-hexyl}-amino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol, triphenylacetate salt;Vilanterol triphenylacetate sal
CAS NO.:503070-58-4
Empirical Formula: C44H49Cl2NO7
Molecular Weight: 774.78
MDL number:
EINECS: 638-763-2
| Pack Size | Price | Stock | Quantity |
| 10MG | RMB576.15 | In Stock |
|
| 50MG | RMB2326.42 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Melting point: | 131.9-134.2℃ |
| storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere |
| solubility | Dichloromethane (Slightly), Methanol (Slightly) |
| form | Solid |
| color | White to Off-White |
| Stability: | Hygroscopic |
| InChIKey | KLOLZALDXGTNQE-NETKZVBLNA-N |
| SMILES | C(C1C=CC=CC=1)(C1C=CC=CC=1)(C1C=CC=CC=1)C(=O)O.[C@H](C1C=CC(O)=C(CO)C=1)(O)CNCCCCCCOCCOCC1C(=CC=CC=1Cl)Cl |&1:22,r| |
Description and Uses
Vilanterol Trifenatate is a long-acting β2 adrenergic receptor Agonist with alonger than 24-hour activity in humans, and is being developed to be used in combination with FF. It is also highly selective for the β2-receptor, with over 1000-fold greater selectivity compared to β1-receptors. It demonstrates prolonged bronchodilation in subjects with asthma and COPD.
Safety
| Symbol(GHS) | ![]() GHS07 |
| Signal word | Warning |
| Hazard statements | H315-H319 |
| Precautionary statements | P264-P280-P302+P352+P332+P313+P362+P364-P305+P351+P338+P337+P313 |



![(1R)-2-(6-[(2-[(2,6-dichlorophenyl)methyl]oxyethyl)oxy]-hexylamino)-1-(2,2-dimethyl-4H-1,3-benzodioxin-6-yl)ethanol](https://img.chemicalbook.com/CAS/20150408/GIF/503068-37-9.gif)



